The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort.
 
Emilie Le Rhun
Consulting or Advisory Role - Adastra Pharmaceuticals; Bayer; Leo Pharma; Seagen
 
Patrick Devos
No Relationships to Disclose
 
Sebastian Winklhofer
No Relationships to Disclose
 
Hafida Lmalem
No Relationships to Disclose
 
Dieta Brandsma
No Relationships to Disclose
 
Priya Kumthekar
Stock and Other Ownership Interests - EnClear Therapies; Vivacitas Oncology
Consulting or Advisory Role - Affinia Therapeutics; Biocept; BioClinica; ElevateBio; EnClear Therapies; Janssen; Novocure; Orbus Therapeutics; SDP Oncology; Sintetica
Research Funding - Angiochem; DNAtrix; Genentech; Novocure; Orbus Therapeutics
Patents, Royalties, Other Intellectual Property - Utility patent for ANG 1005. No financial gain, no royalties.
 
Marion Smits
Honoraria - GE Healthcare (Inst)
 
Joerg Tonn
Honoraria - CarThera
Research Funding - Munich surgical imaging (Inst); Novocure (Inst)
 
Kurt A. Jaeckle
Stock and Other Ownership Interests - Entegrion
 
Matthias Preusser
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BMJ Journals; Bristol-Myers Squibb; CMC Contrast; Daiichi Sankyo; Gerson Lehrman Group; GlaxoSmithKline; Lilly; Medahead; MedMedia; Merck Sharp & Dohme; Mundipharma; Novartis; Roche; Sanofi; Tocagen
Research Funding - Abbvie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); Roche (Inst)
 
Michael J. Glantz
Consulting or Advisory Role - Biocept
Research Funding - cns pharmaceuticals (Inst); Denovo Biopharma (Inst); European Organisation for Research and Treatment of Cancer (EORTC) (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); ImmunoCellular Therapeutics (Inst); Ono Pharmaceutical (Inst); RTOG (Inst); Sunovion (Inst); Triphase Accelerator Corp (Inst); Vascular Biogenics (Inst)
 
Patrick Y. Wen
Consulting or Advisory Role - Agios; AstraZeneca; Bayer; Black Diamond Therapeutics; Blue Earth Diagnostics; Boston Pharmaceuticals; Celularity; Chimerix; Day One Biopharmaceuticals; ElevateBio; Imvax; Integral Health; Karyopharm Therapeutics; Merck; Mundipharma; Novartis; Novocure; Nuvation Bio; Prelude Therapeutics; QED Therapeutics; Sapience Therapeutics; Tocagen; Vascular Biogenics; VBI Vaccines; Voyager Therapeutics
Research Funding - Agios (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Beigene (Inst); Celgene (Inst); Chimerix (Inst); Karyopharm Therapeutics (Inst); Kazia Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Oncoceutics (Inst); Puma Biotechnology (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)
 
Martin Bendszus
Consulting or Advisory Role - B. Braun; Bayer; Boehringer Ingelheim; Grifols; Merck; Neuroscios; Novartis; Teva; Vascular Dynamics
Research Funding - Deutsche Forschungsgemeinschaft (Inst); European Union (Inst); Federal Ministry of Education and Research (Inst); Hopp Foundation (Inst); Siemens (Inst); Stryker (Inst)
 
Michael Weller
Honoraria - Adastra Pharmaceuticals; Merck Serono; Nerviano Medical Sciences; Philogen
Consulting or Advisory Role - Bristol-Myers Squibb; Karyopharm Therapeutics; Medac; Orbus Therapeutics; Ymabs Therapeutics Inc
Research Funding - Apogenix (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); Quercegen Pharmaceuticals (Inst)